We also need to remember right now sitting on $10 mill cash and diluted market value is about $37 million.
Of that $10 million I actually think less will be spend away on R & D and majority is held for an acquisition which is only going to boost earnings, so if we don't acquire likely cash holds near $10 from general operating cash flow and profits. Or if short term a few million is pumped in to Zoleo it may be as a loan/contributed equity which is refunded once it cranks up fully.
Zoleo messages sent are booming, indications are sales are strong, Irridium themselves were amazed at the growth and so on, this is still the game changing entity and it is not understood still and the value is not being recognised virtually at all.
BCC Price at posting:
37.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)